Advanced non-small cell Lung Cancer (NSCLC) Nivolumab in advanced NSCLC with Squamous Epithelial Histology

被引：0
|
作者：
Sankawa, Yuri
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [41] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Dragnev, K. H.
    Seltzer, M.
    Rigas, J. R.
    DiSalvo, W. M.
    Simeone, S.
    Johnstone, D.
    Nugent, W.
    Waxman, S.
    Dmitrovsky, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [42] Comorbidity and survival in advanced non-small cell lung cancer (NSCLC) veteran patients
    Chang, V. T.
    Hoover, D. R.
    Cogswell, J.
    Cholankeril, M.
    Badin, S.
    Yang, W.
    Yan, H.
    Gonzalez, M. L.
    Einhorn, J.
    Kasimis, B. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Measures of aggressive care in advanced non-small cell lung cancer (NSCLC) patients
    McCannon, J.
    Jackson, V. A.
    Billings, J. A.
    Pirl, W. F.
    Greer, J.
    Lynch, T. J.
    Temel, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] FUNCTIONAL DECLINE IN PATIENTS WITH ADVANCED STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Murnane, A.
    Krishnasamy, M.
    Denehy, L.
    Granger, C.
    Aranda, S.
    Mileshkin, L.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S27 - S28
  • [45] Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
    Moya-Horno, Irene
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [46] Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC)
    Bluthgen, M. V.
    Caramella, C.
    Faivre, L.
    Rosellini, S.
    Facchinetti, F.
    Haspinger, E.
    Ferte, C.
    Ammari, S.
    Michiels, S.
    Soria, J. C.
    Besse, B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S645 - S646
  • [47] Thrombosis complicating advanced non-small cell lung cancer (NSCLC) treatment.
    Aiguire, KB
    Rigas, J
    Dragnev, K
    Zacharski, L
    Virginia, B
    Disalvo, W
    Williams, I
    Carey, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 749S - 749S
  • [48] EXPERIENCE OF USING ERLOTINIB FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Kanazawa, Kenya
    Ishida, Takashi
    Suzuki, Aya
    Tachihara, Motoko
    Minemura, Hiroyuki
    Sekine, Satoko
    Oshima, Kengo
    Yokouchi, Hiroshi
    Watanabe, Kana
    Tanino, Yoshinori
    Munakata, Mitsuru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1310 - S1310
  • [49] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [50] Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC)
    Reck, M
    ANTICANCER RESEARCH, 2005, 25 (3A) : 1501 - 1506
12345